Maja J.A de Jonge: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Capmatinib in MET Exon 14âMutated or MET -Amplified NonâSmall-Cell Lung Cancer

Wolf, JÃ¼rgen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B., Groen, Harry J.M., Tan, Daniel S.W., Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V., Smit, Egbert F., Souquet, Pierre-Jea

Journal:

New England Journal of Medicine

Year:

2020

File:

PDF, 582 KB

2020

2

Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib

Emma Guttman-Yassky, Alain Mita, Maja De Jonge, Lesley Matthews, Sean McCarthy, Kenneth K. Iwata, Jaap Verweij, Eric K. Rowinsky, James G. Krueger

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 1.96 MB

english, 2010

3

Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells

Yamamoto, Wataru, Verweij, Jaap, de Bruijn, Peter, de Jonge, Maja JA, Takano, Hiroshi, Nishiyama, Masahiko, Kurihara, Minoru, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Year:

2001

Language:

english

File:

PDF, 270 KB

english, 2001

4

Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT)

van Lent, Liza G. G., Stoel, Nicole K., van Weert, Julia C. M., van Gurp, Jelle, de Jonge, Maja J. A., Lolkema, Martijn P., Gort, Eelke H., Pulleman, Saskia M., Oomen-de Hoop, Esther, Hasselaar, Jeroe

Journal:

BMC Palliative Care

Year:

2019

Language:

english

File:

PDF, 678 KB

english, 2019

5

Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT)

van Lent, Liza G. G., Stoel, Nicole K., van Weert, Julia C. M., van Gurp, Jelle, de Jonge, Maja J. A., Lolkema, Martijn P., Gort, Eelke H., Pulleman, Saskia M., Oomen-de Hoop, Esther, Hasselaar, Jeroe

Journal:

BMC Palliative Care

Year:

2019

File:

PDF, 678 KB

2019

6

Femtomole Quantitation of 7-Ethyl-10-hydroxycamptothecine (SN-38) in Plasma Samples by Reversed-Phase High-Performance Liquid Chromatography

Peter de Bruijn, Maja J.A. de Jonge, Jaap Verweij, Walter J. Loos, Kees Nooter, Gerrit Stoter, Alex Sparreboom

Journal:

Analytical Biochemistry

Year:

1999

Language:

english

File:

PDF, 61 KB

english, 1999

7

Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces

Alex Sparreboom, Peter de Bruijn, Maja J.A de Jonge, Walter J Loos, Gerrit Stoter, Jaap Verweij, Kees Nooter

Journal:

Journal of Chromatography B: Biomedical Sciences and Applications

Year:

1998

Language:

english

File:

PDF, 162 KB

english, 1998

8

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

Pieter E H Van Dijkhuizen, Maja Bulatović, Marloes W Heijstek, Nico M Wulffraat, Saskia M F Pluijm, Robert de Jonge

Journal:

Pediatric Rheumatology

Year:

2011

Language:

english

File:

PDF, 84 KB

english, 2011

9

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

EH Pieter Van Dijkhuizen, Maja Bulatović, Marloes W Heijstek, Nico M Wulffraat, Saskia MF Pluijm, Robert de Jonge

Journal:

Pediatric Rheumatology

Year:

2011

Language:

english

File:

PDF, 84 KB

english, 2011

10

Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor

Paul Hamberg, Margaret M. Woo, Lin-Chi Chen, Jaap Verweij, Maria Grazia Porro, Lily Zhao, Wenkui Li, Diane van der Biessen, Sunil Sharma, Thomas Hengelage, Maja de Jonge

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 285 KB

english, 2011

11

Ecthyma gangrenosum caused byPseudomonas aeruginosain a patient with astrocytoma treated with chemotherapy

Filip Yves Francine Léon De Vos, Tom Alexander Middelburg, Caroline Seynaeve, Maja J. A. de Jonge

Journal:

Journal of Infection and Chemotherapy

Year:

2010

Language:

english

File:

PDF, 203 KB

english, 2010

12

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib

Neeltje Steeghs, Ron H. J. Mathijssen, Judith A. M. Wessels, Anne-Joy de Graan, Tahar van der Straaten, Mariangela Mariani, Bernard Laffranchi, Silvia Comis, Maja J. A. de Jonge, Hans Gelderblom, Henk

Journal:

Investigational New Drugs

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

13

Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry

Peter de Bruijn, Inge M. Ghobadi Moghaddam-Helmantel, Maja J.A. de Jonge, Thorsten Meyer, Mei-Ho Lam, Jaap Verweij, Erik A.C. Wiemer, Walter J. Loos

Journal:

Journal of Pharmaceutical and Biomedical Analysis

Year:

2009

Language:

english

File:

PDF, 318 KB

english, 2009

14

Oral Topoisomerase 1 Inhibitors in Adult Patients: Present and Future

Hans A.J. Gelderblom, Maja J.A. de Jonge, Alex Sparreboom, Jaap Verweij

Journal:

Investigational New Drugs

Year:

1999

Language:

english

File:

PDF, 134 KB

english, 1999

15

Renal Toxicities of Chemotherapy

Maja J.A. de Jonge, Jaap Verweij

Journal:

Seminars in Oncology

Year:

2006

Language:

english

File:

PDF, 233 KB

english, 2006

16

Danusertib , an aurora kinase inhibitor

Meulenbeld, Hielke J, Mathijssen, Ron HJ, Verweij, Jaap, de Wit, Ronald, de Jonge, Maja JA

Journal:

Expert Opinion on Investigational Drugs

Year:

2012

Language:

english

File:

PDF, 370 KB

english, 2012

17

Role of pharmacogenetics in irinotecan therapy

Floris A. de Jong, Maja J.A. de Jonge, Jaap Verweij, Ron H.J. Mathijssen

Journal:

Year:

2006

Language:

english

File:

PDF, 246 KB

english, 2006

18

QTc prolongation and/or oncology drug development: Who’s in danger?

Maja de Jonge, Jaap Verweij

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 103 KB

english, 2008

19

Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: Results of a pharmacokinetic study

Jos J. Kitzen, Christian Puozzo, Maja J. de Jonge, Maud Brandely, Jaap Verweij

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 106 KB

english, 2010

20

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

Maja J.A. de Jonge, Marije Slingerland, Walter J. Loos, Erik A.C. Wiemer, Herman Burger, Ron H.J. Mathijssen, Judith R. Kroep, Margret A.G. den Hollander, Diane van der Biessen, Mei-Ho Lam, Jaap Verwe

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 238 KB

english, 2010

21

Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design

Jaap Verweij, Maja de Jonge, Ferry Eskens, Stefan Sleijfer

Journal:

Molecular Oncology

Year:

2012

Language:

english

File:

PDF, 218 KB

english, 2012

22

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients

Bulatović Ćalasan, Maja, den Boer, Ethan, de Rotte, Maurits C F J, Vastert, Sebastiaan J, Kamphuis, Sylvia, de Jonge, Robert, Wulffraat, Nico M

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 333 KB

english, 2015

23

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis

de Rotte, Maurits C F J, den Boer, Ethan, de Jong, Pascal H P, Pluijm, Saskia M F, Bulatović Ćalasan, Maja, Weel, Angelique E, Huisman, A Margriet, Gerards, Andreas H, van Schaeybroeck, Barbara, Wulff

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 1.03 MB

english, 2015

24

Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity

Pingen, Marieke, Wensing, Annemarie, Fransen, Katrien, De Bel, Annelies, de Jong, Dorien, Hoepelman, Andy, Magiorkinis, Emmanouil, Paraskevis, Dimitrios, Lunar, Maja M, Poljak, Mario, Nijhuis, Monique

Journal:

Year:

2014

Language:

english

File:

PDF, 777 KB

english, 2014

25

Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study

van Dijkhuizen, Evert, Bulatović Ćalasan, Maja, Pluijm, Saskia, de Rotte, Maurits, Vastert, Sebastiaan J, Kamphuis, Sylvia, de Jonge, Robert, Wulffraat, Nico M

Journal:

Pediatric Rheumatology

Year:

2015

Language:

english

File:

PDF, 516 KB

english, 2015

26

The potential of 3T high-resolution magnetic resonance imaging for diagnosis, staging, and follow-up of retinoblastoma

de Jong, Marcus C., de Graaf, Pim, Brisse, Hervé J., Galluzzi, Paolo, Göricke, Sophia L., Moll, Annette C., Munier, Francis L., Beck Popovic, Maja, Moulin, Alexandre P., Binaghi, Stefano, Castelijns,

Journal:

Survey of Ophthalmology

Year:

2015

Language:

english

File:

PDF, 2.29 MB

english, 2015

27

Effects of impaired renal function on the pharmacokinetics and toxicity of i.v. ZD9331, a novel non-polyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors

de Jonge, Maja JA, Glimelius, B, Verweij, Jaap, van Groeningen, C, Bonneterre, J, de Vries, EGE, Culine, S, Young, J, Smith, Rob, Droz, J

Journal:

Anti-Cancer Drugs

Year:

2002

Language:

english

File:

PDF, 168 KB

english, 2002

28

Gender-dependent pharmacokinetics of topotecan in adult patients

Loos, Walter J, Gelderblom, Hans J, Verweij, Jaap, Brouwer, Eric, de Jonge, Maja JA, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Year:

2000

Language:

english

File:

PDF, 120 KB

english, 2000

29

Mesoscale Characterization of Nanoparticles Distribution Using X-ray Scattering

Gommes, Cedric J., Prieto, Gonzalo, Zecevic, Jovana, Vanhalle, Maja, Goderis, Bart, de Jong, Krijn P., de Jongh, Petra E.

Journal:

Angewandte Chemie

Year:

2015

Language:

english

File:

PDF, 1.70 MB

english, 2015

30

Mesoscale Characterization of Nanoparticles Distribution Using X-ray Scattering

Gommes, Cedric J., Prieto, Gonzalo, Zecevic, Jovana, Vanhalle, Maja, Goderis, Bart, de Jong, Krijn P., de Jongh, Petra E.

Journal:

Angewandte Chemie International Edition

Year:

2015

Language:

english

File:

PDF, 1.72 MB

english, 2015

31

Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans

Loos, Walter J, Verweij, Jaap, Gelderblom, Hans J, de Jonge, Maja JA, Brouwer, Eric, Dallaire, Brian K, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 434 KB

1999

32

Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin

Mathijssen, Ron HJ, van Alphen, Robbert J, de Jonge, Maja JA, Verweij, Jaap, de Bruijn, Peter, Loos, Walter J, Nooter, Kees, Vernillet, Laurent, Stoter, Gerrit, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Year:

1999

File:

PDF, 578 KB

1999

33

Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment

van Herpen, Carla M.L., Lassen, Ulrik, Desar, Ingrid M.E., Brown, Kathryn H., Marotti, Marcelo, de Jonge, Maja J.A.

Journal:

Anti-Cancer Drugs

Year:

2013

Language:

english

File:

PDF, 460 KB

english, 2013

34

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma

Jung, Joonil, Lee, Joon Sang, Dickson, Mark A., Schwartz, Gary K., Le Cesne, Axel, Varga, Andrea, Bahleda, Rastilav, Wagner, Andrew J., Choy, Edwin, de Jonge, Maja J., Light, Madelyn, Rowley, Steve, M

Journal:

Nature Communications

Year:

2016

Language:

english

File:

PDF, 444 KB

english, 2016

35

MINI01.03: Phase (Ph) I Study of the Safety and Efficacy of the cMET Inhibitor Capmatinib (INC280) in Patients with Advanced cMET+ NSCLC

Bauer, Todd M., Schuler, Martin, Berardi, Rossana, Lim, Wan-Teck, Van Geel, Robin, De Jonge, Maja, Azaro, Analia, Gottfried, Maya, Han, Ji-Youn, Lee, Dae Ho, Wollner, Mira, Hong, David, Vogel, Arndt,

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 99 KB

english, 2016

36

Phase I and pharmacokinetic study of DE-310 in patients with advanced solid tumors.

Soepenberg, Otto, de Jonge, Maja J a, Sparreboom, Alex, de Bruin, Peter, Eskens, Ferry a L M, de Heus, Gerda, Wanders, Jantien, Cheverton, Peter, Ducharme, Murray P, Verweij, Jaap

Journal:

Clinical cancer research : an official journal of the American Association for Cancer Research

Year:

2005

Language:

english

File:

PDF, 316 KB

english, 2005

37

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

de Jonge, Maja, de Weger, Vincent A., Dickson, Mark A., Langenberg, Marlies, Le Cesne, Axel, Wagner, Andrew J., Hsu, Karl, Zheng, Wei, Macé, Sandrine, Tuffal, Gilles, Thomas, Koruth, Schellens, Jan H.

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 464 KB

english, 2017

38

Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation

van der Biessen, Diane A., van der Helm, Peer G., Klein, Dennis, van der Burg, Simone, Mathijssen, Ron H., Lolkema, Martijn P., de Jonge, Maja J.

Journal:

Psycho-Oncology

Year:

2017

Language:

english

File:

PDF, 718 KB

english, 2017

39

Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug Development

De Jonge, Maja J. A., Verweij, Jaap

Journal:

Hematology (Maney Publishing)

Year:

1996

Language:

english

File:

PDF, 1.52 MB

english, 1996

40

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer

van der Biessen, Diane A. J., Gietema, Jourik A., de Jonge, Maja J. A., Desar, Ingrid M. E., den Hollander, Martha W., Dudley, Matthew, Dunbar, Martin, Hetman, Robert, Serpenti, Camille, Xiong, Hao, M

Journal:

Investigational New Drugs

Year:

2018

Language:

english

File:

PDF, 717 KB

english, 2018

41

Cover Image

van der Biessen, Diane A., van der Helm, Peer G., Klein, Dennis, van der Burg, Simone, Mathijssen, Ron H., Lolkema, Martijn P., de Jonge, Maja J.

Journal:

Psycho-Oncology

Year:

2018

File:

PDF, 150 KB

2018

42

Self-reported quality of life and hope in phase-I trial participants: An observational prospective cohort study

van der Biessen, Diane A., Oldenmenger, Wendy H., van der Helm, Peer G., Klein, Dennis, Oomen-de Hoop, Esther, Mathijssen, Ron H., Lolkema, Martijn P., de Jonge, Maja J.

Journal:

European Journal of Cancer Care

Year:

2018

Language:

english

File:

PDF, 651 KB

english, 2018

43

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis

de Rotte, Maurits C. F. J., Pluijm, Saskia M. F., de Jong, Pascal H. P., Bulatović Ćalasan, Maja, Wulffraat, Nico M., Weel, Angelique E. A. M., Lindemans, Jan, Hazes, J. M. W., de Jonge, Robert, Abu-S

Journal:

Year:

2018

Language:

english

File:

PDF, 1.01 MB

english, 2018

44

A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours

de Weger, Vincent A., de Jonge, Maja, Langenberg, Marlies H. G., Schellens, Jan H. M., Lolkema, Martijn, Varga, Andrea, Demers, Brigitte, Thomas, Koruth, Hsu, Karl, Tuffal, Gilles, Goodstal, Samantha,

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 424 KB

english, 2018

45

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

de Jonge, Maja J. A., Steeghs, Neeltje, Lolkema, Martijn P., Hotte, Sebastien J., Hirte, Hal W., van der Biessen, Diane A. J., Abdul Razak, Albiruni R., De Vos, Filip Y. F. L., Verheijen, Remy B., Sch

Journal:

Targeted Oncology

Year:

2019

File:

PDF, 719 KB

2019

46

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520

Verheijen, Remy B., van der Biessen, Diane A. J., Hotte, Sebastien J., Siu, Lillian L., Spreafico, Anna, de Jonge, Maja J. A., Pronk, Linda C., De Vos, Filip Y. F. L., Schnell, David, Hirte, Hal W., S

Journal:

Targeted Oncology

Year:

2019

File:

PDF, 642 KB

2019

47

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520

Verheijen, Remy B., van der Biessen, Diane A. J., Hotte, Sebastien J., Siu, Lillian L., Spreafico, Anna, de Jonge, Maja J. A., Pronk, Linda C., De Vos, Filip Y. F. L., Schnell, David, Hirte, Hal W., S

Journal:

Targeted Oncology

Year:

2019

Language:

english

File:

PDF, 642 KB

english, 2019

48

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations

Mathijssen, Ron H.J., Verweij, Jaap, de Jonge, Maja J.A., Nooter, Kees, Stoter, Gerrit, Sparreboom, Alex

Journal:

Journal of Clinical Oncology

Year:

2002

File:

PDF, 104 KB

2002

49

Phase I Study of 3-Week Schedule of Irinotecan Combined With Cisplatin in Patients With Advanced Solid Tumors

de Jonge, Maja J. A., Sparreboom, Alex, Planting, André S. T., van der Burg, Maria E. L., de Boer-Dennert, Maureen M., Steeg, Judith ter, Jacques, Christian, Verweij, Jaap

Journal:

Journal of Clinical Oncology

Year:

2000

Language:

english

File:

PDF, 79 KB

english, 2000

50

Phase I and Pharmacokinetic Study of the Oral Farnesyl Transferase Inhibitor SCH 66336 Given Twice Daily to Patients With Advanced Solid Tumors

Eskens, Ferry A.L.M., Awada, Ahmad, Cutler, David L., de Jonge, Maja J.A., Luyten, Gré P.M., Faber, Marije N., Statkevich, Paul, Sparreboom, Alex, Verweij, Jaap, Hanauske, Axel-R., Piccart, Martine

Journal:

Journal of Clinical Oncology

Year:

2001

File:

PDF, 79 KB

2001